Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating CMS-D001 tablets for adults with moderate to severe plaque psoriasis, currently in Phase 2/Phase 3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CMS-D001

Snippet

Sponsor: Dermavon Holdings Limited | Conditions: Moderate to Severe Plaque Psoriasis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING